Ken Griffin's position in TG Therapeutics is currently worth $5 Million. That's 0.01% of their equity portfolio (1506th largest holding). The first TG Therapeutics trade was made in Q4 2013. Since then Ken Griffin bought shares 56 more times and sold shares on 40 occasions. The investor's estimated purchase price is $5.42 Million, resulting in a loss of 7.8%.